Table 5.
Incremental predictive value of the TyG index for ASCVD events and all-cause mortality
| C-statistic (95% CI) | P-value | Category-free NRI (95% CI) | P-value | IDI (95% CI) | P-value | |
|---|---|---|---|---|---|---|
| ASCVD events | ||||||
| Clinical risk factors | 0.7866 (0.7773–0.7960) | – | – | – | – | |
| Clinical risk factors + TG | 0.7870 (0.7776–0.7963) | < 0.001 | 0.1021 (0.0588–0.1454) | < 0.001 | < 0.0001 (0–0.0010) | 0.3513 |
| Clinical risk factors + FBG | 0.7877 (0.7783–0.7970) | < 0.001 | 0.0455 (0.0009–0.0902) | 0.0459 | 0.0003 (0–0.0.0006) | 0.0198 |
| Clinical risk factors + TyG index | 0.7883 (0.7790–0.7976) | < 0.001 | 0.1607 (0.1160–0.2054) | < 0.001 | 0.0004 (0.0002–0.0006) | 0.0003 |
| All-cause mortality | ||||||
| Clinical risk factors | 0.7132 (0.7004–0.7260) | – | – | – | – | |
| Clinical risk factors + TG | 0.7135 (0.7007–0.7263) | < 0.001 | 0.0784 (0.0275–0.1293) | 0.0038 | < 0.0001 (0–0.0001) | 0.0890 |
| Clinical risk factors + FBG | 0.7138 (0.7011–0.7266) | < 0.001 | − 0.0309 ( − 0.0837–0.0218) | 0.2536 | 0.0010 (0.0005–0.0015) | < 0.001 |
| Clinical risk factors + TyG index | 0.7143 (0.7015–0.7271) | < 0.001 | 0.1235 (0.0705–0.1766) | < 0.001 | 0.0003 (0.0002–0.0005) | < 0.001 |
ASCVD atherosclerotic cardiovascular disease, TG triglyceride, FBG fasting bloodglucose, TyG index triglyceride-glucose index, BMI body mass index, SBP systolic blood pressure, CVD cardiovascular disease, TC total cholesterol, HDL-C high density lipoproteincholesterol, LDL-C low density lipoproteincholesterol, hs-CRP high sensitivity C-reactive protein